Morepen gets USFDA nod to market generic anti-allergy drug

Drug firm Morepen Laboratories on Friday said it has received approval from the US health regulator to market its anti-allergy drug Fexofinadine in the American market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rwJw75
via IFTTT